Gene · 1890
Papers4,467
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
121 to 140 of 4,467
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Discovery of PANoptosis-related signatures correlates with immune cell infiltration in psoriasis. | PLoS One | 2024 | 39480805 | PubTator, text mining | PubMed |
| Tumor-associated macrophages confer resistance to chemotherapy (Trifluridine/Tipiracil) in digestive cancers by overexpressing thymidine phosphorylase. | Cancer Lett | 2024 | 39454852 | PubTator, text mining | PubMed |
| Thymidine phosphorylase mediates SARS-CoV-2 spike protein enhanced thrombosis in K18-hACE2TG mice. | Thromb Res | 2024 | 39442286 | PubTator, text mining | PubMed |
| Primary mitochondrial diseases. | Handb Clin Neurol | 2024 | 39322395 | PubTator, text mining | PubMed |
| 5-Fluorouracil metabolic pathway genes predict recurrence risk following adjuvant S-1 therapy: Results of an ancillary analysis from a phase III trial of resected biliary tract cancer (JCOG1202A1). | J Hepatobiliary Pancreat Sci | 2024 | 39318258 | PubTator, text mining | PubMed |
| Theoretical basis, state and challenges of living cell-based drug delivery systems. | Theranostics | 2024 | 39267776 | PubTator, text mining | PubMed |
| Are cities under bright lights more innovative? Evidence from China. | Heliyon | 2024 | 39253158 | PubTator, text mining | PubMed |
| Genetic analysis from multiple cohorts implies causality between 2200 druggable genes, telomere length, and leukemia. | Comput Biol Med | 2024 | 39216403 | PubTator, text mining | PubMed |
| The senescence-associated secretome of Hedgehog-deficient hepatocytes drives MASLD progression. | J Clin Invest | 2024 | 39190624 | PubTator, text mining | PubMed |
| Investigating potential novel therapeutic targets and biomarkers for ankylosing spondylitis using plasma protein screening. | Front Immunol | 2024 | 39185422 | PubTator, text mining | PubMed |
| Novel mitochondrial-related gene signature predicts prognosis and immunological status in glioma. | Transl Cancer Res | 2024 | 39145059 | PubTator, text mining | PubMed |
| Implications of TP-positive CAFs in the Bone Invasion of Oral Squamous Cell Carcinoma. | Anticancer Res | 2024 | 39060037 | PubTator, text mining | PubMed |
| Endometrial scratching in unexplained repeated implantation failure causes two competing forces, angiogenesis and anti-angiogenesis: An RCT study. | Int J Reprod Biomed | 2024 | 39035633 | PubTator, text mining | PubMed |
| Identification and role of differentially expressed genes/proteins between pulmonary tuberculosis patients and controls across lung tissues and blood samples. | Immun Inflamm Dis | 2024 | 39023413 | PubTator, text mining | PubMed |
| An acid-activatable fluorouracil prodrug for colorectal cancer synergistic therapy. | Acta Biomater | 2024 | 39013485 | PubTator, text mining | PubMed |
| A New Histology-Based Prognostic Index for Aggressive T-Cell lymphoma: Preliminary Results of the "TCL Urayasu Classification". | J Clin Med | 2024 | 38999437 | PubTator, text mining | PubMed |
| Facile benzothiazole-triazole based thiazole derivatives as novel thymidine phosphorylase and α-glucosidase inhibitors: Experimental and computational approaches. | Enzyme Microb Technol | 2024 | 38917733 | PubTator, text mining | PubMed |
| Exploring the role of CD8+ T cells in clear renal cell carcinoma metastasis. | FEBS Open Bio | 2024 | 38872260 | PubTator, text mining | PubMed |
| Multi-cohort validation: A comprehensive exploration of prognostic marker in clear cell renal cell carcinoma. | Int Immunopharmacol | 2024 | 38781609 | PubTator, text mining | PubMed |
| Lysosomal dysfunction and overload of nucleosides in thymidine phosphorylase deficiency of MNGIE. | J Transl Med | 2024 | 38741129 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/1890/papers?page=7